Drug Substitution < Drug Therapy, Combination < Drug Users

Facettes : Author.f

List of bibliographic references

Number of relevant bibliographic references: 32.
[0-20] [0 - 20][0 - 32][20-31][20-40]

Ident.	Authors (with country if any)	Title
000003 (2010)	Andrew Ratsela ; Michael Polis ; Sibongiseni Dhlomo ; Sean Emery ; Greg Grandits ; Paul Khabo ; Thandeka Khanyile ; Stephanus Komati ; James D. Neaton ; Lionel Chris David Naidoo ; Daphne Magongoa ; Duma Qolohle	A randomized factorial trial comparing 4 treatment regimens in treatment-naive HIV-infected persons with AIDS and/or a CD4 cell count <200 cells/μL in South Africa.
000048 (2010)	Roland Landman ; M B Diallo ; N F Ngom Gueye ; C Toure Kane ; S. Mboup ; M B Koita Fall ; B. Ndiaye ; G. Peytavin ; Y. Bennai ; A. Benalycherif ; P M Girard ; P S Sow	Efficacy and safety of unboosted atazanavir in combination with lamivudine and didanosine in naive HIV type 1 patients in Senegal.
000059 (2010)	Jon Cohen	AIDS research. Bioethicists assail a celebrated TB/HIV treatment trial.
000176 (2010)	B. Chevalier ; J. Margery ; M. Sane ; P. Camara ; N. Lefebvre ; M. Gueye ; M. Thiam ; J-D Perrier-Gros-Claude ; F. Simon ; M. Fabre ; C. Soler ; V. Herve ; P S Mbaye ; J-M Debonne	[Epidemiology of the resistance of Mycobacterium tuberculosis to antituberculosis drugs at the main hospital in Dakar, Senegal. A 4-year retrospective study (2000-2003)].
000200 (2010)	P J Peters ; J. Stringer ; M S Mcconnell ; J. Kiarie ; W. Ratanasuwan ; P. Intalapaporn ; D. Potter ; W. Mutsotso ; I. Zulu ; C B Borkowf ; O. Bolu ; J T Brooks ; P J Weidle	Nevirapine-associated hepatotoxicity was not predicted by CD4 count ≥250 cells/μL among women in Zambia, Thailand and Kenya.
000353 (2010)	Elise Arrivé ; Marie-Laure Chaix ; Eric Nerrienet ; Stéphane Blanche ; Christine Rouzioux ; Divine Avit ; Leang Sim Kruy ; James Mcintyre ; Leakhena Say ; Glenda Gray ; Didier K. Ekouévi ; François Dabis	Maternal and nenonatal tenofovir and emtricitabine to prevent vertical transmission of HIV-1: tolerance and resistance.
000405 (2010)	C William Wester ; Ann Muir Thomas ; Hermann Bussmann ; Sikhulile Moyo ; Joseph M. Makhema ; Tendani Gaolathe ; Vladimir Novitsky ; Max Essex ; Victor Degruttola ; Richard G. Marlink	Non-nucleoside reverse transcriptase inhibitor outcomes among combination antiretroviral therapy-treated adults in Botswana.
000410 (2010)	Quarraisha Abdool Karim ; Salim S. Abdool Karim ; Cheryl Baxter ; Gerald Friedland ; Tanuja Gengiah ; Andrew Gray ; Anneke Grobler ; Kogileum Naidoo ; Nesri Padayatchi ; Wafaa El-Sadr	The SAPIT trial provides essential evidence on risks and benefits of integrated and sequential treatment of HIV and tuberculosis.
000413 (2011)		Safety and effectiveness of antiretroviral drugs during pregnancy, delivery and breastfeeding for prevention of mother-to-child transmission of HIV-1: the Kesho Bora Multicentre Collaborative Study rationale, design, and implementation challenges.
000423 (2010)	Jeremy Nuttall	Microbicides in the prevention of HIV infection: current status and future directions.
000435 (2010)	Doaa Elsherbiny ; Yuan Ren ; Helen Mcilleron ; Gary Maartens ; Ulrika S H. Simonsson	Population pharmacokinetics of lopinavir in combination with rifampicin-based antitubercular treatment in HIV-infected South African children.
000452 (2011)	D Cristina Stefan ; David K. Stones ; Linda Wainwright ; Robert Newton	Kaposi sarcoma in South African children.
000455 (2010)	Edana Cassol ; Susan Malfeld ; Phetole Mahasha ; Schalk Van Der Merwe ; Sharon Cassol ; Chris Seebregts ; Massimo Alfano ; Guido Poli ; Theresa Rossouw	Persistent microbial translocation and immune activation in HIV-1-infected South Africans receiving combination antiretroviral therapy.
000462 (2010)	Landry Tsague ; Fatima Oliveira Tsiouris ; Rosalind J. Carter ; Veronicah Mugisha ; Gilbert Tene ; Elevanie Nyankesha ; Stephania Koblavi-Deme ; Placidie Mugwaneza ; Eugenie Kayirangwa ; Ruben Sahabo ; Elaine J. Abrams	Comparing two service delivery models for the prevention of mother-to-child transmission (PMTCT) of HIV during transition from single-dose nevirapine to multi-drug antiretroviral regimens.
000491 (????)	Ernesto Hernández Pérez ; Halima Dawood	Stavudine-induced hyperlactatemia/lactic acidosis at a tertiary communicable diseases clinic in South Africa.
000516 (2010)	Salim S. Abdool Karim ; Kogieleum Naidoo ; Anneke Grobler ; Nesri Padayatchi ; Cheryl Baxter ; Andrew Gray ; Tanuja Gengiah ; Gonasagrie Nair ; Sheila Bamber ; Aarthi Singh ; Munira Khan ; Jacqueline Pienaar ; Wafaa El-Sadr ; Gerald Friedland ; Quarraisha Abdool Karim	Timing of initiation of antiretroviral drugs during tuberculosis therapy.
000565 (2010)	Niel Malan ; Jun Su ; Marco Mancini ; Rong Yang ; Victoria Wirtz ; Judith Absalon ; Donnie Mcgrath	Gastrointestinal tolerability and quality of life in antiretroviral-naive HIV-1-infected patients: data from the CASTLE study.
000A83 (2017)	James Hakim ; Victor Musiime ; Alex J. Szubert ; Jane Mallewa ; Abraham Siika ; Clara Agutu ; Simon Walker ; Sarah L. Pett ; Mutsa Bwakura-Dangarembizi ; Abbas Lugemwa ; Symon Kaunda ; Mercy Karoney ; Godfrey Musoro ; Sheila Kabahenda ; Kusum Nathoo ; Kathryn Maitland ; Anna Griffiths ; Margaret J. Thomason ; Cissy Kityo ; Peter Mugyenyi ; Andrew J. Prendergast ; A Sarah Walker ; Diana M. Gibb	Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa.
000A97 (2017)	Mark A. Boyd ; Janaki Amin ; Patrick W G. Mallon ; Nagalingeswaran Kumarasamy ; Johan Lombaard ; Robin Wood ; Ploenchan Chetchotisakd ; Praphan Phanuphak ; Lerato Mohapi ; Iskandar Azwa ; Waldo H. Belloso ; Jean-Michel Molina ; Jennifer Hoy ; Cecilia L. Moore ; Sean Emery ; David A. Cooper	Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study.
000D50 (2017)	Ebrahim Variava ; Farai R. Sigauke ; Jennifer Norman ; Modiehi Rakgokong ; Petudzai Muchichwa ; Andre Mochan ; Gary Maartens ; Neil A. Martinson	Brief Report: Late Efavirenz-Induced Ataxia and Encephalopathy: A Case Series.
000D83 (2017)	David I. Dolling ; Ruth L. Goodall ; Michael Chirara ; James Hakim ; Peter Nkurunziza ; Paula Munderi ; David Eram ; Dinah Tumukunde ; Moira J. Spyer ; Charles F. Gilks ; Pontiano Kaleebu ; David T. Dunn ; Deenan Pillay	The virological durability of first-line ART among HIV-positive adult patients in resource limited settings without virological monitoring: a retrospective analysis of DART trial data.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/PubMed/Corpus

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i -k "Drug Therapy, Combination" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i  \
                -Sk "Drug Therapy, Combination" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaSubSaharaV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Drug Therapy, Combination
}}

---

This area was generated with Dilib version V0.6.32. Data generation: Mon Nov 13 19:31:10 2017. Site generation: Wed Mar 6 19:14:32 2024